<?xml version="1.0" encoding="UTF-8"?>
<ref id="B141-pharmaceuticals-12-00157">
 <label>141.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Jurgeit</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>McDowell</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Moese</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Meldrum</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Schwendener</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Greber</surname>
    <given-names>U.F.</given-names>
   </name>
  </person-group>
  <article-title>Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects</article-title>
  <source>PLoS Pathog.</source>
  <year>2012</year>
  <volume>8</volume>
  <elocation-id>e1002976</elocation-id>
  <pub-id pub-id-type="doi">10.1371/journal.ppat.1002976</pub-id>
  <pub-id pub-id-type="pmid">23133371</pub-id>
 </element-citation>
</ref>
